SUBSTITUTED TRICYCLIC COMPOUNDS AS FGFR INHIBITORS
申请人:Incyte Corporation
公开号:US20170137424A1
公开(公告)日:2017-05-18
The present invention relates to tricyclic compounds, and pharmaceutical compositions of the same, that are inhibitors of one or more FGFR enzymes and are useful in the treatment of FGFR-associated diseases such as cancer.
Substituted tricyclic compounds as FGFR inhibitors
申请人:Incyte Corporation
公开号:US10131667B2
公开(公告)日:2018-11-20
The present invention relates to tricyclic compounds, and pharmaceutical compositions of the same, that are inhibitors of one or more FGFR enzymes and are useful in the treatment of FGFR-associated diseases such as cancer.